» Articles » PMID: 35517510

The Potential Role of Mitochondrial Acetaldehyde Dehydrogenase 2 in Urological Cancers From the Perspective of Ferroptosis and Cellular Senescence

Overview
Specialty Cell Biology
Date 2022 May 6
PMID 35517510
Authors
Affiliations
Soon will be listed here.
Abstract

Overproduction of reactive oxygen species (ROS) and superlative lipid peroxidation promote tumorigenesis, and mitochondrial aldehyde dehydrogenase 2 (ALDH2) is associated with the detoxification of ROS-mediated lipid peroxidation-generated reactive aldehydes such as 4-hydroxy-2-nonenal (4-HNE), malondialdehyde, and acrolein due to tobacco smoking. ALDH2 has been demonstrated to be highly associated with the prognosis and chemoradiotherapy sensitivity of many types of cancer, including leukemia, lung cancer, head and neck cancer, esophageal cancer, hepatocellular cancer, pancreatic cancer, and ovarian cancer. In this study, we explored the possible relationship between ALDH2 and urological cancers from the aspects of ferroptosis, epigenetic alterations, proteostasis, mitochondrial dysfunction, and cellular senescence.

Citing Articles

Mechanisms and preventive measures of ALDH2 in ischemia‑reperfusion injury: Ferroptosis as a novel target (Review).

Han L, Zhai W Mol Med Rep. 2025; 31(4).

PMID: 40017132 PMC: 11876945. DOI: 10.3892/mmr.2025.13470.


[Activation of ALDH2 alleviates hypoxic pulmonary hypertension in mice by upregulating the SIRT1/PGC-1α signaling pathway].

Wang L, Bian F, Ma F, Fang S, Ling Z, Liu M Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(10):1955-1964.

PMID: 39523096 PMC: 11526457. DOI: 10.12122/j.issn.1673-4254.2024.10.14.


Molecular mechanisms of ferroptosis and its effects on bladder cancer.

Li R, Ning Y, Yuan Y, Yang X Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(2):286-295.

PMID: 38755725 PMC: 11103069. DOI: 10.11817/j.issn.1672-7347.2024.230352.


Oxidative stress is two-sided in the treatment of acute myeloid leukemia.

Fan C, Yang X, Yan L, Shi Z Cancer Med. 2024; 13(9):e6806.

PMID: 38715546 PMC: 11077289. DOI: 10.1002/cam4.6806.


ALDH2 as an immunological and prognostic biomarker: Insights from pan-cancer analysis.

Shen X, Yan Z, Huang Y, Zhu Q, Zhang G, Ci H Medicine (Baltimore). 2024; 103(16):e37820.

PMID: 38640328 PMC: 11030019. DOI: 10.1097/MD.0000000000037820.


References
1.
Shoeb M, Ansari N, Srivastava S, Ramana K . 4-Hydroxynonenal in the pathogenesis and progression of human diseases. Curr Med Chem. 2013; 21(2):230-7. PMC: 3964795. DOI: 10.2174/09298673113209990181. View

2.
Litovkin K, Van Eynde A, Joniau S, Lerut E, Laenen A, Gevaert T . DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS One. 2015; 10(6):e0130651. PMC: 4472347. DOI: 10.1371/journal.pone.0130651. View

3.
Granados D, Tanguay P, Hardy M, Caron E, de Verteuil D, Meloche S . ER stress affects processing of MHC class I-associated peptides. BMC Immunol. 2009; 10:10. PMC: 2657905. DOI: 10.1186/1471-2172-10-10. View

4.
Wu S, Chen J, Dong P, Zhang S, He Y, Sun L . Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma. BMC Cancer. 2014; 14:836. PMC: 4242595. DOI: 10.1186/1471-2407-14-836. View

5.
Miyasaka K, Kawanami T, Shimokata H, Ohta S, Funakoshi A . Inactive aldehyde dehydrogenase-2 increased the risk of pancreatic cancer among smokers in a Japanese male population. Pancreas. 2005; 30(2):95-8. DOI: 10.1097/01.mpa.0000147084.70125.41. View